Holen Sie sich die Stockscreener-App
34.15
0.03%
-0.010
Sanara Medtech Inc Aktie (SMTI) Neueste Nachrichten
Walleye Capital LLC Makes New $719,000 Investment in Sanara MedTech Inc. $SMTI - MarketBeat
Sanara MedTech (SMTI) Stock Stays Quiet As Profitability Meets Debt Scrutiny - Sahm
(SMTI) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Sanara Medtech earnings missed by $0.02, revenue fell short of estimates - Investing.com Canada
Sanara Medtech Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates - Yahoo Finance
Sanara MedTech (NASDAQ:SMTI) Issues Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
Sanara MedTech Q2 Results: Sales Rise 9% YoY, EPS Misses Estimate - scanx.trade
Sanara MedTech Inc. Q2 2026: Revenue $28.14M, EPS $(0.05) — 10-Q Summary - TradingView
Sanara MedTech (SMTI) grows H1 2026 revenue to $55.9M and trims loss - Stock Titan
MiMedx Group (SMTI partner) clarifies Sanara merger fees and $33 cash-plus-stock deal - Stock Titan
Form 8K Sanara Medtech Inc For: 11 August By Investing.com - Investing.com Nigeria
Sanara MedTech Inc. (SMTI) Releases Q2 2026 Earnings: Revenue Rises 8.9% - Quiver Quantitative
Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock merger terms and corrects fees - Stock Titan
Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) - The Manila Times
Sanara MedTech Q2 revenue rises on soft-tissue product growth - TradingView
Sanara MedTech (SMTI) grows revenue, posts Q2 loss amid pending MIMEDX deal - Stock Titan
Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock per share in merger - Stock Titan
Sanara MedTech (SMTI) Short Interest & Short Float | Updated Aug 2026 - MarketBeat
Sanara Medtech Inc expected to post a loss of 2 cents a shareEarnings Preview - TradingView
Sanara MedTech Inc. (NASDAQ:SMTI) Receives Consensus Recommendation of "Reduce" from Analysts - MarketBeat
Sanara MedTech, Inc. (SMTI) Investigation: Bronstein, Gewirtz & G - The National Law Review
Sanara MedTech (SMTI) Expected to Post Earnings on Wednesday - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech, Inc - The National Law Review
Sanara MedTech (NASDAQ:SMTI) Stock Rating Lowered by Freedom Capital - MarketBeat
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Sanara MedTec - The National Law Review
Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc.SMTI - marketscreener.com
How (SMTI) Movements Inform Risk Allocation Models - news.stocktradersdaily.com
Sanara MedTech (NASDAQ:SMTI) Downgraded by Wall Street Zen to Buy - MarketBeat
SANARA MEDTECH INC : H.C. WAINWRIGHT CUTS TO NEUTRAL FROM BUY; CUTS TARGET PRICE TO $35 FROM $36 - webull.com
Mimedx to buy Sanara for $350M to move beyond wound care - bioworld.com
Is There Now An Opportunity In Sanara MedTech Inc. (NASDAQ:SMTI)? - webull.com
MiMedx to Buy Sanara MedTech for $350M - Medical Product Outsourcing
Sanara MedTech (SMTI) agrees to $350 million cash‑and‑stock acquisition by MiMedx - Stock Titan
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ), Sanara MedTech Inc. (Nasdaq – SMTI), TriCo Bancshares (Nasdaq – TCBK) - GlobeNewswire
MIMEDX To Acquire Sanara MedTech In $350 Million Transaction - Pulse 2.0
MiMedx Group: Sanara Deal Comes At A Poor Time - Seeking Alpha
Sanara MedTech agrees to be acquired by MiMedx - TipRanks
MIMEDX to acquire Sanara MedTech for $350 million By Investing.com - Investing.com Nigeria
Sanara MedTech to Be Acquired by MiMedx in $35-Per-Share Cash-and-Stock Merger - TradingView
MiMedx Q2 sales fall less than expected; set to acquire Sanara MedTech - TradingView
MIMEDX to Acquire Sanara MedTech - The Manila Times
MIMEDX Announces Second Quarter 2026 Operating & Financial Results - GlobeNewswire
MiMedx Group, Inc. entered into a definitive merger agreement to acquire Sanara MedTech Inc. for approximately $340 million. - marketscreener.com
Sanara MedTech Inc. Revenue Breakdown – NASDAQ:SMTI - TradingView
Sanara Medtech Inc (SMTI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
Sanara Medtech Inc (SMTI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Sanara Medtech Inc (SMTI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Sanara Medtech Inc (SMTI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
SMTI|Sanara Medtech Inc|Price:25.560|Chg%:+0.060 - TradingKey
Sanara MedTech Company Profile & Introduction - Moomoo
Sanara MedTech (SMTI) Q1 2026 Earnings: Strong Profitability Surprise with EPS BeatEarnings Season Review - dars.gov.et
Sanara MedTech stock trades steady as advanced wound care growth supports valuation - Ad-hoc-news.de
Trading Systems Reacting to (SMTI) Volatility - Stock Traders Daily
Sanara MedTech Inc. (SMTI) Q1 2026 Earnings: EPS Surprises to Positive Territory Despite Revenue Uncertainty - dars.gov.et
Sanara MedTech Inc. (NASDAQ:SMTI) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Sanara MedTech (SMTI) Rallies 3.5% on Strong Volume; Key Levels in FocusETF Premium Discount - dars.gov.et
Sanara MedTech Inc outlines its wound care focus. Longer-term growth story draws investor interest - Ad-hoc-news.de
Price to sales forward of Sanara MedTech Inc. – NASDAQ:SMTI - TradingView
Price to sales forward of Sanara MedTech Inc. – BOATS:SMTI - TradingView
Price to book forward of Sanara MedTech Inc. – NASDAQ:SMTI - TradingView
Enterprise value to revenue forward of Sanara MedTech Inc. – NASDAQ:SMTI - TradingView
2.90%
1.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):